Non-Current Assets
Total Assets
Neurocrine Biosciences Total Assets increased by 5.9% to $4.91B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.0%, from $3.69B to $4.91B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 21.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
Detailed definition
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Peer comparison
Universal financial metric used by all public companies to define the size of the balance sheet.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.96B | $2.02B | $2.07B | $2.14B | $2.01B | $2.14B | $2.37B | $2.36B | $2.61B | $2.85B | $3.25B | $3.47B | $3.31B | $3.54B | $3.72B | $3.69B | $3.89B | $4.27B | $4.63B | $4.91B |
| QoQ Change | — | +3.1% | +2.7% | +3.5% | -6.5% | +6.9% | +10.5% | -0.4% | +10.7% | +9.0% | +14.2% | +6.8% | -4.8% | +7.0% | +5.2% | -0.8% | +5.5% | +9.7% | +8.6% | +5.9% |
| YoY Change | — | — | — | — | +2.5% | +6.3% | +14.3% | +10.0% | +30.3% | +32.9% | +37.3% | +47.1% | +26.5% | +24.1% | +14.4% | +6.2% | +17.7% | +20.7% | +24.5% | +33.0% |
Range$1.96B – $4.91B
CAGR+21.4%
Avg YoY Growth+21.7%
Median YoY Growth+22.4%
Current Streak4 quarters growth
Total Assets at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's total assets?
- Neurocrine Biosciences (NBIX) reported total assets of $4.91B in Q1 2026.
- How has Neurocrine Biosciences's total assets changed year-over-year?
- Neurocrine Biosciences's total assets increased by 33.0% year-over-year, from $3.69B to $4.91B.
- What is the long-term trend for Neurocrine Biosciences's total assets?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's total assets has grown at a 21.7% compound annual growth rate (CAGR), from $1.73B to $4.63B.
- What does total assets mean?
- The total value of everything the company owns.